Geopolitics & Trade

FDA greenlights the first precision therapy for BRCA2-mutated mCSPC, a highly aggressive prostate cancer, slashing progression risk by 54%.

Tech innovator Jay Walker is launching REVIVE, a media network aiming for 180M homes. This isn't just new content; it's a strategic play in the national information ecosystem.

AIP Realty Trust's $78.7M acquisition of AllTrades pivots on a complex related-party deal and reverse takeover, putting unitholder trust to the test.

TPG RE Finance Trust declared a steady $0.24 dividend. We analyze if this signals portfolio resilience or a strategic play in a volatile market.

The safari park operator swung from a major loss to a $1.9M pre-tax profit, driven by revenue growth and the absence of prior-year proxy battle costs.

Two Bay Area event firms gain a key certification, strategically positioning them to tap into the lucrative healthcare conference market via supplier diversity.

From biopharma to webcomics, shareholder lawsuits reveal the perils of misleading investors. A look at four companies facing legal and financial fallout.

Ripple just secured a federal bank charter for its stablecoin, RLUSD. This landmark move, enabled by the GENIUS Act, could redefine trust in crypto.

Alamo Group's acquisition of Petersen Industries for $166.5M isn't just another deal. It's a strategic move to dominate the waste management equipment market.

A top industrial firm offers a surprising blueprint for fixing healthcare's biggest challenges, from clinician burnout to supply chain woes.

Amid a $2.37B buyout, Weiss Asset Management's increased stake in Avadel Pharma raises questions. Is it a vote of confidence or a strategic power play?

Hedge fund Balyasny Asset Management builds a 1.72% stake in JTC plc, signaling high-stakes maneuvering in the £2.3 billion takeover saga.

A routine filing by hedge fund Balyasny Asset Management may have just put Avadel Pharmaceuticals in the M&A spotlight. Here's what the signal means.

A new book arms working mothers with legal secrets HR won’t share, forcing businesses to rethink their strategic approach to talent and compliance.

When a trusted professional evades over $1 million in taxes, the impact goes beyond the courtroom, shaking public trust and starving community services.

United Imaging Intelligence's new AI agents can reason, act, and report. But are hospitals ready for the business and ethical hurdles of this new era?

Canada Post's 2026 stamp lineup is more than a collection; it's a strategic investment in public health, reconciliation, and community wellness.

Amid a major corporate overhaul, Emergent BioSolutions secures a key FDA approval, signaling a new era for the firm and for U.S. biodefense strategy.

A novel drug for alcohol use disorder gets key scientific backing. It promises the benefits of psychedelics with fewer risks, shaking up a $35B market.

Decibel Cannabis secured approval for a potential 50-1 share consolidation. Is this a sign of weakness or a savvy move to fuel its global expansion?